학술논문
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
Document Type
Article
Author
Source
In: Cancer Immunology, Immunotherapy . (Cancer Immunology, Immunotherapy, 1 January 2020, 69(1):127-134)
Subject
Language
English
ISSN
14320851
03407004
03407004